Peng Chen

机构：Hunan Cancer Hospital, Taiwan Centers for Disease Control, China Academy of Traditional Chinese Medicine Hospital of Ophthalmology · ORCID：0000-0003-3463-0708

发表论文 174 篇 · 总被引 2609 次 · h-index 25

代表论文

• ACAT1 regulates tertiary lymphoid structures and correlates with immunotherapy response in non–small cell lung cancer (2025 · Journal of Clinical Investigation · 被引 20)
• Deciphering decidual deficiencies in recurrent spontaneous abortion and the therapeutic potential of mesenchymal stem cells at single-cell resolution (2024 · Stem Cell Research & Therapy · 被引 10)
• Proteomic profiling and biomarker discovery for predicting the response to PD-1 inhibitor immunotherapy in gastric cancer patients (2024 · Frontiers in Pharmacology · 被引 10)
• Sacituzumab tirumotecan (sac-TMT) in patients (pts) with previously treated locally advanced or metastatic (LA/M) non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: Preliminary results from a phase 2 study. (2025 · Journal of Clinical Oncology · 被引 6)
• Integration of Multi-Scale Profiling and Machine Learning Reveals the Prognostic Role of Extracellular Matrix-Related Cancer-Associated Fibroblasts in Lung Adenocarcinoma (2025 · International Journal of Medical Sciences · 被引 3)
• Relationship between circulating miRNA-222-3p and miRNA-136-5p and the efficacy of docetaxel chemotherapy in metastatic castration-resistant prostate cancer patients (2024 · BMC Urology · 被引 2)